Prelude Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$579K Sell
24,235
-104
-0.4% -$2.49K 0.06% 394
2025
Q1
$605K Buy
24,339
+4,804
+25% +$119K 0.05% 386
2024
Q4
$368K Sell
19,535
-2,400
-11% -$45.2K 0.02% 611
2024
Q3
$330K Buy
21,935
+2,518
+13% +$37.9K 0.02% 732
2024
Q2
$556K Buy
19,417
+4,892
+34% +$140K 0.04% 438
2024
Q1
$424K Buy
14,525
+7,841
+117% +$229K 0.02% 627
2023
Q4
$226K Buy
+6,684
New +$226K 0.01% 767
2023
Q3
Sell
-6,990
Closed -$280K 1164
2023
Q2
$280K Buy
+6,990
New +$280K 0.02% 586
2022
Q3
Sell
-9,837
Closed -$573K 1695
2022
Q2
$573K Buy
9,837
+2,491
+34% +$145K 0.02% 621
2022
Q1
$561K Sell
7,346
-4,481
-38% -$342K 0.02% 638
2021
Q4
$712K Buy
+11,827
New +$712K 0.02% 617
2020
Q3
Sell
-15,447
Closed -$811K 1715
2020
Q2
$811K Buy
15,447
+3,058
+25% +$161K 0.04% 188
2020
Q1
$415K Buy
12,389
+6,875
+125% +$230K 0.03% 185
2019
Q4
$250K Sell
5,514
-3,160
-36% -$143K 0.01% 486
2019
Q3
$330K Sell
8,674
-8,653
-50% -$329K 0.01% 352
2019
Q2
$754K Buy
17,327
+17,121
+8,311% +$745K 0.04% 222
2019
Q1
$8K Buy
+206
New +$8K ﹤0.01% 1155
2017
Q4
Hold
0
1476
2017
Q3
Hold
0
1700
2017
Q2
Hold
0
1677
2017
Q1
Hold
0
1653
2016
Q4
Hold
0
1667
2016
Q3
Sell
-1,144
Closed -$39K 1679
2016
Q2
$39K Sell
1,144
-950
-45% -$32.4K 0.01% 1042
2016
Q1
$111K Sell
2,094
-1,239
-37% -$65.7K 0.02% 658
2015
Q4
$256K Buy
+3,333
New +$256K 0.04% 417
2015
Q1
Sell
-300
Closed -$27K 2002
2014
Q4
$27K Sell
300
-950
-76% -$85.5K ﹤0.01% 1564
2014
Q3
$121K Buy
1,250
+1,150
+1,150% +$111K 0.02% 921
2014
Q2
$9K Buy
+100
New +$9K ﹤0.01% 1652